InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,995.54
(
0.38%
)
US TECH 100
20,562.00
(
0.10%
)
Dow Jones
43,988.99
(
0.59%
)
Brent Oil
73.89
(
0.00%
)
Bitcoin
76,346.52
(
-0.29%
)
Post# of 253566
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

drbio45

Send PM Follow Ignore
Followers 36
Posts 3185
Boards Moderated 0
Alias Born 10/18/2003

drbio45

Re: None

Thursday, 12/24/2015 12:58:28 PM

Thursday, December 24, 2015 12:58:28 PM

Post# of 253566
It would be interesting to hear about some new approaches to AD outside of the amyloid approach. I came across a paper suggesting targeting TLRs, such as TLR9, could be a beneficial approach in AD. Not clear to me if this was distinctly related to the amyloid hypothesis or not though. Need to find that again.

Take a look at PKC epsilon. Neurotrope

https://www.tcd.ie/academicunits/schools/medicine/physiology/assets/docs13_14/lynchma/PG4700%20PG4750%20SS%20Cell%20Physiology/PKC%20and%20aging.pdf
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up